Nature Technology Corporation (NTC) provides safe and effective products to enhance nucleic acid-based gene therapeutics, and DNA vaccines, as well as process technology to aid in the manufacturing of these products. NTC’s proprietary products include antibiotic-free selection vectors (RNA-OUT), and Nanoplasmids™, both of which can be used in non-viral and viral vector derived gene therapy and cell therapy biologics including: CAR T-cell therapies, stem cell therapies, adoptive immunotherapies, passive immunotherapies, allergy immunotherapies, DNA vaccines, tolerizing DNA vaccines, regenerative medicines, cancer gene therapy, gene replacement therapies, gene editing therapies, viral vector production and more. NTC also provides cost effective outsourcing of product development services including custom gene design, vector construction, retrofitting, and plasmid DNA manufacturing.